Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity	Infections, Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, respiratory system disorder, respiratory tract infectious disorder, type 1 diabetes mellitus	Active, not recruiting	Not applicable	2024-12-13		NCT04769037

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cambridge Biomedical Campus, Cambridge, UK	1
Helmholtz Zentrum München	11
Kinderkrankenhaus auf der Bult	4
Medical University of Warsaw	89
Royal Victoria Infirmary, Newcastle upon Tyne, UK	1
Skane University Hospital	71
Technical University of Munich	85
Universitaire Ziekenhuizen KU Leuven	262
University Hospital Carl Gustav Carus	10

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
AUF DER BULT, Kinder- und Jugendkrankenhaus	Hanover	Germany	1
Department of Paediatrics Medical University of Warsaw	Warsaw	Poland	1
Institute of Diabetes Research, Helmholtz Zentrum Munich, Germany, and Forschergruppe Diabetes, Technical University Munich (TUM), School of Medicine, Klinikum rechts der Isar	Munich	Germany	1
Lund University, Skane University Hospital SUS	Malmö	Sweden	1
Royal Victoria Infirmary, Newcastle upon Tyne	Newcastle	United Kingdom	1
University Department of Paediatrics, Cambridge Biomedical Campus	Cambridge	United Kingdom	1
University Hospitals Leuven Faculty of Medicine, Catholic University of Leuven	Leuven	Belgium	1
Universitätsklinikum Carl Gustav Carus Technische Universität Dresden	Dresden	Germany	1